Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8588)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 28, 2016 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Radiology
ISSN
1949-8470
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sheth RA, Feldman AS, Paul E, Thiele EA, Walker TG. Angiographic and volumetric effects of mammalian target of rapamycin inhibitors on angiomyolipomas in tuberous sclerosis. World J Radiol 2016; 8(3): 308-315 [PMID: 27027863 DOI: 10.4329/wjr.v8.i3.308] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8470/full/v8/i3/308.htm |
| Number | Citing Articles |
| 1 |
Takashi Hatano, Kentaro Chikaraishi, Hiroyuki Inaba, Katsuhisa Endo, Shin Egawa. Outcomes of everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis complex: A single institution experience in Japan. International Journal of Urology 2016; 23(10): 833 doi: 10.1111/iju.13168
|
| 2 |
Wei-Chung Hsiao, Jeng-Dau Tsai, Shao-Chun Wang, Sung-Lang Chen. Mammalian target of rapamycin inhibitor and transarterial embolization for treatment of tuberous sclerosis complex patients with renal angiomyolipoma. Urological Science 2018; 29(2): 100 doi: 10.4103/UROS.UROS_19_17
|
| 3 |
Rahul A. Sheth, Adam S. Feldman, Elahna Paul, Elizabeth A. Thiele, T. Gregory Walker. Sporadic versus Tuberous Sclerosis Complex–Associated Angiomyolipomas: Predictors for Long-Term Outcomes following Transcatheter Embolization. Journal of Vascular and Interventional Radiology 2016; 27(10): 1542 doi: 10.1016/j.jvir.2016.05.029
|
| 4 |
Joshua A. Samuels. Treatment of Renal Angiomyolipoma and Other Hamartomas in Patients with Tuberous Sclerosis Complex. Clinical Journal of the American Society of Nephrology 2017; 12(7): 1196 doi: 10.2215/CJN.08150816
|
| 5 |
John J. Bissler, Norio Nonomura, Klemens Budde, Bernard A. Zonnenberg, Michael Fischereder, Maurizio Voi, Anne-Laure Louveau, Fabian Herbst, E. Martina Bebin, Paolo Curatolo, Andrea Zonta, Elena Belousova, Kathrin Eller. Angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis. PLOS ONE 2018; 13(9): e0201005 doi: 10.1371/journal.pone.0201005
|
| 6 |
Pike-See Cheah, Shilpa Prabhakar, David Yellen, Roberta L. Beauchamp, Xuan Zhang, Shingo Kasamatsu, Roderick T. Bronson, Elizabeth A. Thiele, David J. Kwiatkowski, Anat Stemmer-Rachamimov, Bence György, King-Hwa Ling, Masao Kaneki, Bakhos A. Tannous, Vijaya Ramesh, Casey A. Maguire, Xandra O. Breakefield. Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberin. Science Advances 2021; 7(2) doi: 10.1126/sciadv.abb1703
|
| 7 |
Sharon Samueli, Klaus Abraham, Anastasia Dressler, Gudrun Gröppel, Angelika Mühlebner-Fahrngruber, Theresa Scholl, Gregor Kasprian, Franco Laccone, Martha Feucht. Efficacy and safety of Everolimus in children with TSC - associated epilepsy – Pilot data from an open single-center prospective study. Orphanet Journal of Rare Diseases 2016; 11(1) doi: 10.1186/s13023-016-0530-z
|
| 8 |
Takashi Hatano, Mahito Atsuta, Hiroyuki Inaba, Katsuhisa Endo, Shin Egawa. Effect of everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis complex: an evaluation based on tumor density. International Journal of Clinical Oncology 2018; 23(3): 547 doi: 10.1007/s10147-017-1224-9
|
| 9 |
Kazutoshi Fujita, Norio Nonomura. Editorial Comment to Outcomes of everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis complex: A single institution experience in Japan. International Journal of Urology 2016; 23(10): 838 doi: 10.1111/iju.13200
|
| 10 |
Takashi Hatano, Taishi Matsu-ura, Kei-ichiro Mori, Hiroyuki Inaba, Katsuhisa Endo, Mayumi Tamari, Shin Egawa. Effect of everolimus treatment for regrown renal angiomyolipoma associated with tuberous sclerosis complex after transcatheter arterial embolization. International Journal of Clinical Oncology 2018; 23(6): 1134 doi: 10.1007/s10147-018-1325-0
|
| 11 |
María José Buj Pradilla, Teresa Martí Ballesté, Roser Torra, Felipe Villacampa Aubá. Recommendations for imaging-based diagnosis and management of renal angiomyolipoma associated with tuberous sclerosis complex. Clinical Kidney Journal 2017; 10(6): 728 doi: 10.1093/ckj/sfx094
|